Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 2
1991 1
1992 2
1994 2
1998 1
1999 1
2000 4
2001 2
2002 1
2003 2
2004 2
2005 1
2006 1
2007 1
2008 2
2010 1
2012 2
2015 1
2016 1
2017 1
2018 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Phosphatases driving mitosis: pushing the gas and lifting the brakes.
Johnson ES, Kornbluth S. Johnson ES, et al. Prog Mol Biol Transl Sci. 2012;106:327-41. doi: 10.1016/B978-0-12-396456-4.00008-0. Prog Mol Biol Transl Sci. 2012. PMID: 22340723 Review.
For this reason, studies on mitotic progression have focused heavily on the activation of MPF (M phase promoting factor), a cyclin-dependent kinase responsible for phosphorylating proteins that execute the dynamic events of mitosis. ...It is now clear that there exists a s …
For this reason, studies on mitotic progression have focused heavily on the activation of MPF (M phase promoting factor), a cyclin-de …
Across the meiotic divide - CSF activity in the post-Emi2/XErp1 era.
Wu JQ, Kornbluth S. Wu JQ, et al. J Cell Sci. 2008 Nov 1;121(Pt 21):3509-14. doi: 10.1242/jcs.036855. J Cell Sci. 2008. PMID: 18946022 Review.
The discovery of the Mos-MAPK pathway and characterization of the anaphase-promoting complex/cyclosome (APC/C) as a central regulator of M-phase exit provided the framework for a molecular understanding of CSF. ...
The discovery of the Mos-MAPK pathway and characterization of the anaphase-promoting complex/cyclosome (APC/C) as a central regulator of …
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III.
Webb AJ, Ullman NL, Morgan TC, Muschelli J, Kornbluth J, Awad IA, Mayo S, Rosenblum M, Ziai W, Zuccarrello M, Aldrich F, John S, Harnof S, Lopez G, Broaddus WC, Wijman C, Vespa P, Bullock R, Haines SJ, Cruz-Flores S, Tuhrim S, Hill MD, Narayan R, Hanley DF; MISTIE and CLEAR Investigators. Webb AJ, et al. Stroke. 2015 Sep;46(9):2470-6. doi: 10.1161/STROKEAHA.114.007343. Epub 2015 Aug 4. Stroke. 2015. PMID: 26243227 Free PMC article. Review.
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at The Mount Sinai Hospital.
Korelitz BI. Korelitz BI. Mt Sinai J Med. 2000 May;67(3):214-26. Mt Sinai J Med. 2000. PMID: 10828907
The authors were privileged to have been able to share in this undertaking, along with many others, including Moschcowitz, Klemperer, Otani, Crohn, Ginzburg, Oppenheimer, Garlock, Lyons, Marshak, Janowitz, Aufses, Waye, Greenstein, Sachar, Meyers, Gelernt, Mayer, Lichtiger and …
The authors were privileged to have been able to share in this undertaking, along with many others, including Moschcowitz, Klemperer, Otani, …
PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.
Margolis SS, Walsh S, Weiser DC, Yoshida M, Shenolikar S, Kornbluth S. Margolis SS, et al. EMBO J. 2003 Nov 3;22(21):5734-45. doi: 10.1093/emboj/cdg545. EMBO J. 2003. PMID: 14592972 Free PMC article.
It has been known for over a decade that inhibition of protein phosphatase 1 (PP1) activity prevents entry into M phase, but the relevant substrate has not been identified. We report here that PP1 is required for dephosphorylation of the Cdc2-directed phosphatase Cdc25 at …
It has been known for over a decade that inhibition of protein phosphatase 1 (PP1) activity prevents entry into M phase, but the rele …
Early Functional Connectome Integrity and 1-Year Recovery in Comatose Survivors of Cardiac Arrest.
Sair HI, Hannawi Y, Li S, Kornbluth J, Demertzi A, Di Perri C, Chabanne R, Jean B, Benali H, Perlbarg V, Pekar J, Luyt CE, Galanaud D, Velly L, Puybasset L, Laureys S, Caffo B, Stevens RD; Neuroimaging for Coma Emergence and Recovery (NICER) Consortium. Sair HI, et al. Radiology. 2018 Apr;287(1):247-255. doi: 10.1148/radiol.2017162161. Epub 2017 Oct 18. Radiology. 2018. PMID: 29043908
Aven-dependent activation of ATM following DNA damage.
Guo JY, Yamada A, Kajino T, Wu JQ, Tang W, Freel CD, Feng J, Chau BN, Wang MZ, Margolis SS, Yoo HY, Wang XF, Dunphy WG, Irusta PM, Hardwick JM, Kornbluth S. Guo JY, et al. Curr Biol. 2008 Jul 8;18(13):933-42. doi: 10.1016/j.cub.2008.05.045. Epub 2008 Jun 19. Curr Biol. 2008. PMID: 18571408 Free PMC article.
RESULTS: In characterizing Aven protein, a previously reported apoptotic inhibitor, we have found that Aven can function as an ATM activator to inhibit G2/M progression. Aven bound to ATM and Aven overexpressed in cycling Xenopus egg extracts prevented mitotic entry and in …
RESULTS: In characterizing Aven protein, a previously reported apoptotic inhibitor, we have found that Aven can function as an ATM activator …
Role of CD40 ligand in Mycobacterium avium infection.
Hayashi T, Rao SP, Meylan PR, Kornbluth RS, Catanzaro A. Hayashi T, et al. Infect Immun. 1999 Jul;67(7):3558-65. doi: 10.1128/IAI.67.7.3558-3565.1999. Infect Immun. 1999. PMID: 10377139 Free PMC article.
To determine whether CD40-CD40 ligand (CD40L) interactions play a role in M. avium infection, we studied the ability of CD40L to restrict M. avium replication in human monocyte-derived macrophages (MDM) in vitro. ...Intracellular growth of M. avium in these M …
To determine whether CD40-CD40 ligand (CD40L) interactions play a role in M. avium infection, we studied the ability of CD40L to rest …
33 results